Pharmaceutical IP and competition law in South Africa: overview
Pharmaceutical IP and competition law in South Africa: overview by Danie Dohmen, Jenny Pienaar, Alexis Apostolidis and Jeanette Visagie
A Q&A guide to pharmaceutical IP and competition law in South Africa.
The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports.
To read the full Q&A, visit Thomson Reuters Practical Law.
For information on pharmaceutical pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability, visit Medicinal product regulation and product liability in South Africa: overview.
President Ramaphosa Approves Plant Health Bill
President Cyril Ramaphosa has signed the Plant Health Bill into law, introducing measures to tackle the issue of plant pests that threaten domestic agriculture and could affect South Africa’s agricu...
March 19 2025
Advancing IP Education in Africa: Highlights from the WIPO-South Africa Summer School on Intellectual Property
The WIPO-South Africa Summer School on Intellectual Property (IP) has concluded another successful session. Hosted in partnership with South Africa’s Department of Science, Technology and Innovation...
March 19 2025
The pop-up that popped in and popped out: Off Rhode trade mark concerns
Influencer beauty gurus of South Africa were abuzz this past weekend with the announcement of a Rhode pop-up store at Mall of Africa. TikTokers wasted no time in running to secure the bag and soon fee...
March 19 2025
